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Abstract
Background: Closure of salvage laryngectomy defects with vascularized tissue remains controversial.
Methods: We evaluate outcomes in patients who required repair of a fistula after attempted primary closure of
salvage laryngectomy defect and assess risk factors for persistent fistula. Between 2001 and 2010, 20 patients were
treated for pharyngocutaneous fistulae after primary closure of a salvage laryngectomy. All patients required free
flap repair for definitive fistula management.
Results: Patients presented with fistulae from one to 18 months in duration; median time to closure was seven
days. Radial forearm free flap was used in 86% of patients. With free flap alone 50% of patients achieved fistula
closure. Additional procedures improved closure rate to 85%. Recipient vessels were used in the neck in 54.5%,
compared to internal mammary vessels in 45.5%. Hypothyroidism was identified as a risk factor for persistent fistula
(p = 0.01). Chronic steroid use (p = 0.08) did not reach significance as a risk factor for fistula closure.
Gastroesophageal reflux disease was newly diagnosed or noted as a comorbidity in 14 patients (70%) in this study.
It did not reach statistical significance as a risk factor in refistulization (p = 0.12). Complications included leak,
carotid blowout, infection, free flap loss, and late refistulization. Overall flap failure in this study was 4.5%.
Conclusions: Delayed secondary repair of pharygocutaneous fistulas after salvage laryngectomy is associated with
a higher complication rate and poor success rates compared to use of vascularized tissue at the time of salvage
laryngectomy. Prolonged wound healing in these patients is associated with hypothyroidism.
Keywords: Laryngectomy, Free flap, Pharyngocutaneous fistula, Head and neck cancer, Wound reconstruction,
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Introduction
There are almost 12,000 newly diagnosed cases of laryn-
geal cancer every year in the United States [1]. The pri-
mary advantage of chemoradiation protocols for
squamous cell carcinoma of the head and neck is organ
preservation–with the potential for preservation of nat-
ural speech and swallowing function. Unfortunately,
structural preservation does not equate to normal func-
tion. While an adequate voice has been reasonably easy
to maintain, adequate swallowing has not [2-4]. Current
management trends have favored radiation or chemora-
diation over surgical options in the spirit of that goal.
As a result, there have been a growing number of
patients presenting with recurrent disease requiring sal-
vage laryngectomy. Closure of salvage laryngectomy
defects after chemoradiation is associated with a 3%-
65% [5,6] wound complication rate, with the most com-
mon and significant problem being fistula formation.
Although it is well known that concomitant chemora-
diotherapy intensifies the clinical side effects, the com-
plex pathophysiology must continue to be investigated.
Tissue in the field of radiation treatment undergoes
multiple types of injury, most commonly referred to as
radiation-induced fibroatrophy [7]. In brief, the vascular
endothelial cells experience oxidative injury, which leads
to the recruitment of inflammatory cells, and a cascade
of cytokines. Fibroblasts and myofibroblasts secrete
excessive and altered extracellular matrix. The capillary
network is damaged both acutely and chronically. This
impacts the normal surrounding mucosa in addition to
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laryngectomy is friable and poorly vascularized.
It has been recently been shown that introduction of
vascularized tissue at the time of initial pharyngeal clo-
sure reduces the fistula rate and need for operative
intervention [5,8,9]. However, primary closure of salvage
laryngectomy defects remains the standard-of-care at
most institutions. Although many post-salvage laryn-
gectomy fistulae can be managed conservatively, poor
tissue vascularity, malnutrition, and hypothyroidism
[6,10] can lead to chronic fistula formation which
requires aggressive reconstruction to definitively re-
establish an oral diet.
Our strategy to secondarily repair post-laryngectomy
defects has evolved significantly over the past decade as
a result of experience with these complex wounds. We
present our experience and the reconstructive strategy
refined from this experience as applied to pharyngocuta-
neous defects after salvage laryngectomy in a review of
20 patients who underwent secondary fistula repair.
Patients and Methods
This retrospective study reviewed over 1300 free flap
reconstructions performed between 2001 and 2010. We
identified 20 patients who required reconstruction of
their pharyngocutaneous fistula after salvage laryngect-
omy with primary closure. Patients were primarily trea-
ted at our institution, as well as referred from the
surrounding region after fistula development. After
Institutional Review Board approval all data was gath-
ered from patient charts and electronic medical record.
Fistulae were categorized as wound dehiscence result-
ing in fistula or stricture-associated fistula, based on the
senior author’s pan endoscopy exam. Patients with tra-
cheoesophageal puncture-related fistula were not
included in this study. Detailed demographic informa-
tion was obtained including prior surgeries, radiation
treatment, duration of fistula, weight loss, and comor-
bidities. Endocrine status was assessed by thyroid stimu-
lating hormone (TSH) levels, when deemed necessary.
Nutritional status based on albumin and prealbumin
levels were collected on a case-by-case basis. Comorbid-
ities were obtained based on patient history, medication
list, and/or laboratory data. All patients eventually
required free flap reconstruction. Free flap is defined as
free tissue transfer from another location in the body
with microvascular anastomosis of donor vasculature to
selected recipient vessels in the neck. Information on
the type of free flap used, location of vessel anastomosis,
presence of internal dopplers, length of hospital stay,
and complications was obtained. In the post-operative
period barium swallow was used to assess for fistula clo-
sure. Pedicled flaps were used in certain patients,
defined as tissue flaps which are rotated on a pedicled
blood supply, such as a pectoralis muscular or musculo-
cutaneous flap. Local flap use was also noted in the
patients’ course of treatment. Local flaps were defined
as small cutaneous tissue rearrangements directly adja-
cent to the fistula. Patients were assessed for type of
diet, method of communication, and weight gain during
their follow-up. Patients were followed at least until fis-
tula closure.
Statistical analysis was performed to examine patterns
that predisposed patients to recurrent fistula. Continu-
ous variables were analyzed with t-test. Categorical vari-
ables were analyzed with Fisher’s exact test. For all
analyses, p value < 0.05 was deemed statistically
significant.
Results
Free flaps were performed on all patients to obtain defi-
nitive closure. There were 22 free flaps performed in 20
patients. Table 1 describes each patient’s course of treat-
ment. Approximately 86% of patients had radial forearm
flap (RFFF) reconstruction, but other flaps included
anteriolateral thigh (ALT) and rectus free flaps.
Recipient vessel choice was managed on a case-by-
case basis, dependent on the patients’ previous neck dis-
section status, quality of neck tissue on physical exam,
and experience of the senior author. Internal mammary
vessels (both artery and vein) were chosen as the recipi-
ent vessels in 45.5% of patients. Internal mammary ves-
sels were favored in the later years of this series. Of the
54.5% of patients in which neck vessels were used, most
commonly used was the facial artery, followed by an
unnamed branch of the external carotid system. The
venous system chosen in the neck was most commonly
the facial vein or a large internal jugular vein stump, fol-
lowed by the external jugular vein, and an end-to-side
internal jugular vein anastomosis.
The fistula closure rate with the initial free flap proce-
dure was 50%. Ten patients (50%) had a leak on barium
swallow or refistulized requiring additional procedures.
After a second free flap (Table 1, patient 11), simulta-
neous pectoralis pedicled flap (Table 1, patient 20), or
additional local flaps (Table 1, patients 7, 14, 15) an
overall closure rate of 85% was achieved. Patient 11 had
planned, staged free flaps to obtain closure. He had a
previous pectoralis flap before transfer to our institution.
Six patients (17%) had mild leaks that were managed
conservatively (Table 1, patients 2, 13, 20) or local flap
closure (Table 1, patients 7, 14, 15). Three patients,
even with additional local, pedicled, and free flaps, never
attained fistula closure. Patients with persistent fistula
were eventually lost to follow-up.
Interestingly, the duration of fistula prior to recon-
struction was not found to be a statistically significant
factor in the success of reconstruction. Indications for
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and stricture-related fistula in only three patients. Per-
haps due to the small numbers in the series, patients
with wound dehiscent-related fistula (85%) were much
more likely to achieve successful fistula closure than
those deemed to have stricture-related fistula (15%). Of
the three patients with stricture-related fistula, two of
those three patients (66%) never achieved closure of
their fistulae, compared to only one of 17 wound-dehis-
cent fistulae patients (6%). No patients in this series
have required additional neopharyngeal dilations.
Complications were divided into early (during hospita-
lization) and late (post-discharge). There was one free
flap loss in this series (4.5%). Other complications
included infection (n = 1), hematoma (n = 1), and caro-
tid blowout (n = 2). Of the two patients that suffered
carotid blowout and subsequent ligation, both patients
had prior neck dissections procedures and then under-
went neck vessel anastomosis with subsequent persistent
fistula/failure. One hematoma occurred due to bleeding
from arterial feeding vessels in a rectus flap. Three
patients had failure to close their fistula due to free flap
loss, infection, or persistent late refistulization.
Hypothyroidism was a statistically significant comor-
bidity for refistulization (p = 0.01). Chronic steroid use
(p = 0.08) did not reach significance as a risk factor for
fistula closure. Gastroesophageal reflux disease was
newly diagnosed or noted as a comorbidity in 14
patients (70%) in this study. However, it did not reach
statistical significance as a risk factor in refistulization (p
= 0.12). Three patients eventually required conversion
of their gastrostomy tube to a gastro-jejunostomy tube
to prevent reflux of gastric contents into the pharyngeal
reconstruction.
The average time to fistula closure from the date of
definitive fistula repair was 36 days and the median time
to closure was seven days. Median hospital stay was 7
days (range 4-27 days) and more than half of patients
were discharged on an oral diet on post-operative day
(POD) seven. Median follow-up for patients after
Table 1 Comorbidity, Reconstruction Technique, Complications, and Associated Time to Fistula Closure
Patient Gender Age Comorbidities Duration of
Fistula
(months)
Flap(s) Defect Survival Vessels
(A/V)
Complications Time to
Closure
(days)
Other
1 M 69 None 5 RFFF folded Yes EC/EJ None 7 N
2 M 65 DM, HT, GERD 3 RFFF patch Yes EC/IJ Contained leak 7 N
3 F 47 DM,GERD 3 RFFF folded Yes EC/IJ None 6 N
4 F 67 HT, GERD 13 RFFF tubed Yes F/EJ None 10 N
5 F 66 None 1 RFFF patch Yes F/IJ None 5 N
6 M 59 GERD 4 RFFF folded Yes F/EJ None 40 N
7 M 66 HT, GERD 8 RFFF onlay Yes F/IJ Persistent leak 39 Y
8 F 69 HT, GERD 4 RFFF folded Yes F/IJ None 7 N
9 F 49 DM, Hepatitis 7 RFFF patch Yes F/IJ None 7 N
10 M 53 GERD 13 Rectus patch Yes IM/IM None 9 N
11 M 70 HT 5 Rectus,
RFFF
tubed,
patch
Yes IM/IM,
IM/IM
Diverting fistula, hematoma 35 Y
12 M 53 None 1 RFFF patch Yes IM/IM None 6 N
13 F 67 GERD 2 RFFF onlay Yes IM/IM Contained leak 6 N
14 M 66 HT, GERD 5 ALT patch Yes IM/IM Refistulized 90 Y
15 M 64 DM, HT,
Steroid, GERD
4 RFFF onlay Yes IM/IM PNA, Refistulized 53 Y
16 M 68 Steroid, HT,
GERD
4 RFFF folded No ST/EJ CC blowout, lig, Pec,
persistent leak
Never Y
17 F 75 HT, GERD 7 RFFF folded Yes EC/IJ None 7 N
18 M 54 DM, HT, GERD 1 RFFF folded Yes F/IJ Late pharyngocarotid fistula,
CC stent, Pec, CC lig,
Refistulized
Never Y
19 M 62 HT, GERD 9 RFFF,
RFFF
folded,
onlay
Yes IM/IM,
IM/IM
Neck and chest infection,
refistulized
Never Y
20 M 49 None 18 RFFF/
Pec
patch Yes IM Contained leak 7 N
M, male; F, female; DM, diabetes mellitus; GERD, gastroesophageal reflux disease; HT, hypothyroidism; Steroid, chronic steroid use; RFFF, radial forearm free flap;
ALT, anterolateral thigh free flap; Rectus, rectus abdominis free flap; Pec; pectoralis major pedicled flap; CC, common carotid; EC, external carotid; EJ, external
jugular; IJ, internal jugular; IM, internal mammary; ST, superior thyroid; A, artery; V, vein; PNA, pneumonia; Other = additional procedures performed to facilitate
fistula closure. Y = yes. N = no.
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months. During follow-up patients gained an average of
10 lbs, (p = 0.4).
Most patients (90%) used an electrolarynx for commu-
nication. Two patients underwent secondary tracheoeso-
phageal puncture once the fistula was closed. Nearly
55% of patients returned to a regular or soft diet, 35%
remained on liquid diet after fistula closure, and 10%
were NPO using tube feeds, (Table 2).
In this series of patients 100% patients had prior
radiation therapy, 25% had previous chemotherapy and
47% of patients had prior neck dissection. Of the 13
patients in the later half of the study (2006-2010), four
of those patients (30.7%) had chemotherapy, compared
to only 14.2% of patients (one of seven) between 2001
and 2005. Despite the differences in prior therapy over
time, chemotherapy was not found to be a significant
factor for successful closure, in this study.
Discussion
With the evolution of organ sparing therapy for treat-
ment of laryngeal and hypopharyngeal squamous cell car-
cinoma, chemoradiotherapy has increased over time.
Thus, with laryngectomy becoming a salvage procedure,
wound complications and pharyngocutaneous fistula
have become an increasing concern. Wound healing
complications can have a multifactorial origin including
diabetes, hypothyroidism, radiation dosage, and che-
motherapy [6,8,11]. Previous studies have confirmed the
added benefit of vascularized tissue at the time of phar-
yngeal closure to reduce fistula and promote the return
to oral diet [5,8,9]. In this study we review our recon-
structive experience with patients who suffered pharyn-
gocutaneous fistula after primary closure of a salvage
laryngectomy wound. In our series of 20 patients we have
demonstrated fistula closure to be a complex process in
which only half of patients have definitive fistula closure
with a single procedure. The current study supports the
use of preplanned vascularized tissue use in the wound of
the neopharynx after salvage laryngectomy.
It was elected to reconstruct most patients referred for
fistula repair with radial forearm free flaps (RFFF), how-
ever the techniques of fistula closure varied with time
and increasing experience. Each fistula required analysis
of the amount of remaining mucosa, pliability and quan-
tity of neck skin, and the presence of stricture to formu-
late a reconstructive plan. Patients with stricture-based
fistula had the stricture incised and the free flap tissue
inserted into the band of circumferential stricture, to
allow passage of a 12 or 14 mm salivary bypass tube.
When larger fistula (the classic three-hole defect) were
closed using a single folded flap to reconstitute both the
pharyngeal lining and the external skin, the vascular
pedicle of the RFFF folded on itself and obstructed
venous flow and as result led to refistulization. We
found in the present study that patients who underwent
a “patch” graft using the RFFF to reconstruct the phar-
yngeal lining, and then had good skin quantity and lax-
ity to close the skin primarily overlying the free flap,
had fewer leaks and required fewer additional proce-
dures. Thus, in the patient population with minimal
mucosa and skin available, we deduced over time that
the combination of free flap patch closure with pedicled
pectoralis muscle created the ideal reconstruction. The
technique of folding the radial forearm skin paddle on
itself to obtain closure of the internal and external lining
did not routinely work well because of kinking the pedi-
cle at the fold or re-fistulizing at the de-epithelialized
portion of the skin paddle. An example of staged pector-
alis muscle flap followed by successful folded RFFF is
shown in Figure 1.
One flap failed in the series (4.5% failure rate). In this
RFFF, the recipient vessels were the superior thyroid
artery and external jugular vein. This flap was folded to
allow the distal portion of the forearm to seal the phar-
ynx and proximal paddle to close the neck. This patient
required take-back on POD 2 and was salvaged only to
require additional take-back on POD 3, complete
venous clot was encountered, which was thought to be
secondary the tight folding of the flap.
Rather we have favored the free flap to reconstitute
the pharyngeal lining, while the pectoralis flap provides
well-vascularized tissue as a substrate for skin grafting
or granulating external wound closure. In patients who
have already had attempts at closure via pectoralis flap,
we have repositioned the pectoralis muscle to protect
neck vasculature and relied on staged double free flaps
to seal the neopharynx. Others have reported the benefit
of using a single anterior lateral thigh flap with two skin
paddles to perform internal and external epithelial lining
[12]. It was noted in this study that earlier repair was
less prone to complications [12]. In our patient series,
the data did not support this finding. Most of our fistula
patients presented for repair within the first six months
Table 2 Types of postoperative communication and diet
Variable All patients
n (%)
20 (100)
Communication method
Electrolarynx 18 (90)
Tracheoesophageal puncture 2 (10)
Diet
Regular/Soft 11 (55)
Liquid 7 (35)
NPO/Tube feeding only 2 (10)
NPO, nil per os.
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Page 4 of 7Figure 1 Staged vessel protection, before pharyngocutaneous fistula closure using folded radial forearm free flap. (A) Great vessels
(arrow) bathed in saliva from adjacent pharyngocutaneous fistula, (B) with pectoralis pedicled flap the neck vessels are covered, (C) a negative
pressure dressing facilitates wound care and controls the fistula in the immediate suprastomal area until (D) the wound is well granulated and
(E) a folded radial forearm free flap is used to close the suprastomal fistula several weeks later.
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tula closure. However, we did successfully close pharyn-
gocutaneous fistula of more than 12 months duration in
3 patients without any complications.
As the closure technique has evolved over time, so has
the selection of recipient vessels. In this patient series
donor neck vessels were used 54.5%, most commonly
the facial vessels, and internal mammary vessel were
used in 45.5% of patients. Because neck exploration and
vessel anastomosis was used in the two patients who
developed carotid blowout, the use of cervical vessels in
these patients was reconsidered. Both carotid blowout
patients had previous neck dissection procedures, and
chemoradiotherapy. The repetitive dissection of the che-
moradiated neck with potential exposure to saliva for
free flap vessel anastomosis was felt to significantly
increase the risk for carotid blowout. To this end, the
choice of recipient internal mammary vessels, as seen in
Figure 2, allowed for free flap closure of the fistula with-
out repeated dissection of neck vasculature in the field
of radiation and previous surgical scarring. The combi-
nation of RFFF and internal mammary vessel is ideal
because of the length of the vascular pedicle, the thin
and generous quantity of skin, and the unradiated,
donor vasculature. When the fistula is located suprasto-
mally compared to in the base of tongue region there is
generous length of the vascular pedicle. The use of
transverse cervical vessels is also appropriate in this set-
ting as described by others [12].
Interestingly, when the demographic factors were ana-
lyzed, the duration of the fistula prior to reconstruction
did not impact the success of reconstruction. The length
of time of the fistula being present probably does not
increase the inflammatory and scarring factors in the
wound bed, but more likely that the event of a fistula pre-
cipitates the inflammatory and scarring cascade to occur.
Also, it was noted that untreated hypothyroidism was a
significant comorbidity (p = 0.01) that predisposed to
failure to close the fistula. This finding is also supported
by previous studies [10,13]. Screening TSH levels should
be a routine part of head and neck cancer surveillance. In
patients who develop fistula after primary closure of a
salvage larygectomy, the need for screening TSH is
heightened. In our series of patients, when elevated TSH
levels were noted, institution of thyroid hormone replace-
ment and delay of free flap closure help to improve
wound healing. For example, patient 11 (Table 1), pre-
sented with wound breakdown fistula after salvage laryn-
gectomy, unsuccessful pectoralis pedicled flap closure,
and a TSH level of 97.9. The patient underwent reposi-
tioning of the pectoralis muscle to protect the neck vas-
culature, thyroid hormone replacement therapy, and
wound care. The first free flap stage was delayed several
weeks to facilitate improved healing. A tubed rectus free
flap was successfully performed, as all pharyngeal mucosa
was lost, to intentionally divert saliva away from the
stoma and contralateral neck vessels. Finally, four weeks
after the first free flap, a RFFF was used to patch the
superiorly based (base of tongue) fistula. Figure 2 demon-
strates a patient with similar flap staging.
Recently published literature supports the use of vas-
cularized tissue for decreased fistula in salvage laryn-
gectomy wounds. Driven et al. found that patients
undergoing salvage surgery within one year of complet-
ing concurrent chemoradiotherapy, or high dose radio-
therapy (>64 Gray) were at increased risk for
pharyngocutaneous fistula, 34.2% vs. 15.7% [5]. In 2007,
Withrow et al. noted that use of vascularized free flap
for laryngectomy closure had 18% fistula rate compared
to 50% for primary closure [9]. Others have noted
improvement in rate of pharyngocutaneous fistula after
using pectoralis pedicled flaps for reinforcement of a
primary laryngectomy closure after chemoradiation fail-
ure [8]. In our series of 20 patients we have demon-
strated fistula closure to be a complex process in which
only half of patients have definitive fistula closure with a
single procedure. The current study supports the use of
preplanned vascularized tissue use in the wound of the
neopharynx after salvage laryngectomy. Although this
may add time to an oncologic procedure, simultaneous
planned use of pectoralis pedicled muscle or free flap
tissue does decrease fistula and its associated complica-
tions [9].
Figure 2 Staged free flaps in closure of pharyngocutaneous
fistula, after failure of primary closure in salvage laryngectomy.
(A) After tubed rectus free flap to divert fistula toward base of
tongue region; arrow denotes internal mammary vessel incision site.
(B) Prior to second stage, (C) with second set of internal mammary
vessels, microvascular anastomosis was performed for patch-type
radial forearm free flap in base of tongue region to achieve final
closure.
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Patients that develop fistula after salvage laryngectomy
with primary closure have a constellation of treatment
and demographic factors that make reestablishing an
oral diet a challenge. Choosing vascularized tissue to
reconstitute both the pharyngeal lining and external
skin in our case series is best done with radial forearm
free flap and pedicled pectoralis muscle. Selecting donor
vessels like the internal mammary site can avoid compli-
cations like carotid blowout. Planned preparation of vas-
cularized tissue in a salvage laryngectomy neopharynx
and control of comorbidities in the pre-operative period
can minimize additional procedures and provide the
best outcome for our salvage laryngectomy patients.
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